This new guide helps streamline vaccine sites and eligibility information in one place. Photo courtesy of CVS Health

Are you frustrated by the hoops you're jumping through to get a COVID-19 vaccination? The GoodRx drug-price-comparison app has stepped in to help.

GoodRx just rolled out a guide so you can learn about the COVID-19 vaccine, track its availability, and set up a vaccination appointment in Houston or elsewhere in Texas.

"Vaccine information has been fragmented and availability unclear, so GoodRx has built the go-to destination for all Americans to track the vaccine rollout locally," the company says in a statement.

GoodRx is collecting data from more than 15,000 vaccination sites and is monitoring the country's 70,000 pharmacies as well as state-specific sites to update appointment availability. New information is added as it becomes available.

Among other things, the GoodRx guide tells you who's eligible for vaccinations where you live, who's next in line, and how you can make a vaccination appointment. You can even sign up to receive text messages that alert you when vaccination eligibility changes in your area.

This news comes as Texas Gov. Greg Abbott has reopened the state and lifted the mask mandate — which could put Houstonians at even greater risk.

Meanwhile, throughout Texas, the recent winter storm, power outages, and water shortages hampered the ability to distribute COVID-19 vaccines. As of March 3, Harris County shows some 351,063 confirmed COVD cases, according to most-recent data, and 2,297,878 cases statewide. Information about the Texas vaccination plan is available on the Department of State Health Services website.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.